Means and methods for diagnosing pancreatic cancer

US11726090B2 · kind B2 · utility

Assignees

• Deutsches Krebsforschungszentrum · DE
• QUEEN MARY UNIVERSITY OF LONDON · GB

Inventors

• Christoph Schröder · Heidelberg, DE
• Jorg Hoheisel · Wiesbaden, DE
• Tatjana CRNOGORAC-JURCEVIC · Sidcup, GB

Key dates

• Filing date: Dec 21, 2016
• Grant date: Aug 15, 2023
• Expiry date: Dec 21, 2036

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12Q2600/158
• WIPO field: Measurement
• WIPO sector: Instruments

Abstract

The present invention pertains to the field of cancer diagnosis. Specifically, it relates to a method for diagnosing pancreas cancer in a subject comprising the steps of determining in a sample of a subject suspected to suffer from pancreas cancer the amount of at least one biomarker selected from the biomarkers shown in Table 1 and comparing the said amount of the at least one biomarker with a reference, whereby pancreas cancer is to be diagnosed. The present invention also contemplates a method for identifying whether a subject is in need of a pancreas cancer therapy comprising the steps of the aforementioned methods and the further step of identifying a subject in need of a pancreas cancer therapy if said subject is to be diagnosed to suffer from pancreas cancer. Contemplated are, furthermore, diagnostic devices and kits for carrying out said methods.